Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ED3R
|
|||
Drug Name |
Clopidogrel
|
|||
Synonyms |
(S)-Clopidogrel; Plavix; (+)-Clopidogrel; Clopidogrel [INN:BAN]
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H16ClNO2S
|
|||
Canonical SMILES |
COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
|
|||
InChI |
1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1
|
|||
InChIKey |
GKTWGGQPFAXNFI-HNNXBMFYSA-N
|
|||
CAS Number |
CAS 113665-84-2
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:37941
|
References | Top | |||
---|---|---|---|---|
REF 1 | Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. (C-19-ACS) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.